TXNIP regulates neutrophil platelet aggregates in acute lung injury (ALI), and has been proved to be involved in glucose and lipid metabolism, and NLRP3 inflammasome activation, a known factor for the immunopathogenesis of COVID-19 (56). Here, NLRP3 is linked to acute lung injury.